Skip to content

Sarepta Therapeutics, Inc. SRPT Other current assets

Other current assets at other companies

Pfizer logo
PfizerPFE
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
Arrowhead Research logo
Arrowhead ResearchARWR

Other financials

Income statement

See full
Revenue$730.8M-1.9%
Operating income-$300.4M-961%
Net income$331.0M+174%
EPS (diluted)-$4.60-1,343%

Balance sheet

See full
Cash & equivalents$464.5M+92.8%
Total debt$198.5M-3.4%
Total equity$1.5B+31.7%
Total assets$3.2B-8.3%

Cash flow

See full
Operating cash flow-$202.7M+65.3%
CapEx$2.1M-95.2%
Free cash flow-$204.8M+67.3%

Valuation

See full
Market cap$1.76B-63.1%

Profitability

See full
Operating margin-50.8%-1.6pp
Net margin4.6%+2.4pp
FCF margin-28.7%-9.2pp

Returns & leverage

See full
Return on equity-23.6%-28.5pp
Debt / equity0.1×0.0×
Current ratio4.6×+0.6×

Where this comes from

Reported directly by Sarepta Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.

The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sarepta Therapeutics, Inc.'s other current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sarepta Therapeutics, Inc.'s other current assets?
Sarepta Therapeutics, Inc. (SRPT) reported other current assets of $187.97M in Q1 2026.
How has Sarepta Therapeutics, Inc.'s other current assets changed year-over-year?
Sarepta Therapeutics, Inc.'s other current assets increased by 78.2% year-over-year, from $105.48M to $187.97M.
What is the long-term trend for Sarepta Therapeutics, Inc.'s other current assets?
Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s other current assets has grown at a -4.2% compound annual growth rate (CAGR), from $213.32M to $171.86M.